A long-term follow-up of a case of Rogers syndrome, Thiamine responsive megaloblastic anemia
DOI:
https://doi.org/10.18203/2349-3291.ijcp20232894Keywords:
Anemia, Diabetes, Hearing loss, Thiamine responsiveAbstract
Thiamine-responsive megaloblastic anemia (TRMA) also known as Rogers syndrome is a rare autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and progressive sensorineural deafness. The disease can be manifested anytime between infancy and adolescence, and all the cardinal findings may not be present at the time of the diagnosis. The main defect lies in the active thiamine uptake into cells which is disturbed. Not many cases have been reported about the long-term follow-up of children with this disorder and their associated complications. We hereby report a 14 years follow-up of a girl with Rogers syndrome diagnosed at toddler age with nonresponsive anemia and diabetes and further progressed to have sensorineural hearing loss. Her clinical exome study showed a mutation in the SLC19A2 gene. This experience illustrates the relevance of a detailed evaluation and regular follow-up to assess the progression of the syndrome till her pubertal age.
References
Lorber A, Gazit AZ, Khoury A, Schwartz Y, Mandel H. Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. Pediatr Cardiol. 2003;24:476-81.
Ozdemir MA, Akcakus M, Kurtoglu S, Gunes T, Torun YA. TRMA syndrome (thiamine‐responsive megaloblastic anemia): a case report and review of the literature. Pediatr Diabetes. 2002;3(4):205-9.
Laforenza U, Patrini C, Alvisi C, Faelli A, Licandro A, Rindi G. Thiamine uptake in human intestinal biopsy specimens, including observations from a patient with acute thiamine deficiency. Am J Clin Nutr. 1997;66(2):320-6.
Bay A, Keskin M, Hizli S, Uygun H, Dai A, Gumruk F. Thiamine-responsive megaloblastic anemia syndrome. Int J Hematol. 2010;92:524-6.
Alzahrani AS, Baitei E, Zou M, Shi Y. Thiamine transporter mutation: an example of monogenic diabetes mellitus. Euro J Endocrinol. 2006;155(6):787-92.
Sako S, Tsunogai T, Oishi K. Thiamine-responsive megaloblastic anemia syndrome. NLM. 2003.
Kurtoglu S, Hatipoglu N, Keskin M, Kendirci M, Akcakus M. Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings. J Pediatr Endocrinol Metabol. 2008;21(4):393-8.
Ricketts CJ, Minton JA, Samuel J, Ariyawansa I, Wales JK, Lo IF, et al. Thiamine‐responsive megaloblastic anaemia syndrome: Long‐term follow‐up and mutation analysis of seven families. Acta Paediatrica. 2006;95(1):99-104.
Faraji‐Goodarzi M, Tarhani F, Taee N. Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome. Clin Case Reports. 2020;8(6):991-4.
